Blar i Department of Global Public Health and Primary Care på forfatter "Bjørge, Tone"

Viser treff 41-44 av 44

    • Supplemental folic acid in pregnancy and childhood cancer risk 

      Mortensen, Jan Helge Seglem; Øyen, Nina; Fomina, Tatiana; Melbye, Mads; Tretli, Steinar; Vollset, Stein Emil; Bjørge, Tone (Peer reviewed; Journal article, 2016)
      Background: We investigated the association between supplemental folic acid in pregnancy and childhood cancer in a nationwide study of 687 406 live births in Norway, 1999–2010, and 799 children diagnosed later with cancer. ...

    • Supplemental folic acid in pregnancy and maternal cancer risk 

      Mortensen, Jan Helge Seglem; Øyen, Nina; Fomina, Tatiana; Melbye, Mads; Tretli, Steinar; Vollset, Stein Emil; Bjørge, Tone (Peer reviewed; Journal article, 2015-12)
      Background: There is evidence that increased intake of folate protects against the development of several types of cancer. Some studies have, however, raised concern about the safety of folate in relation to cancer risk. ...

    • Treatment and 30-day mortality after myocardial infarction in prostate cancer patients: A population-based study from Norway 

      Forster, Rachel Bedenis; Kjellstadli, Camilla; Myklebust, Tor Åge; Egeland, Grace M.; Sulo, Gerhard; Bjørge, Tone; Bønaa, Kaare Harald; Juliusson, Pétur Benedikt; Kvåle, Rune (Journal article; Peer reviewed, 2023)
      Introduction: There is limited knowledge about the use of invasive treatment and mortality after acute myocardial infarction (AMI) in prostate cancer (PCa) patients. We therefore wanted to compare rates of invasive treatment ...

    • The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers 

      Fritz, Josef; Bjørge, Tone; Nagel, Gabriele; Manjer, Jonas; Engeland, Anders; Häggström, Christel; Concin, Hans; Teleka, Stanley; Tretli, Steinar; Gylling, Björn; Lang, Alois; Stattin, Pär; Stocks, Tanja; Ulmer, Hanno (Peer reviewed; Journal article, 2020)
      Background: The role of insulin resistance as a mediator in the association of body mass index (BMI) with site-specific cancer risk has, to our knowledge, never been systematically quantified. Methods: Altogether 510 471 ...